中科生物(01237.HK) 发盈喜,预期上半年将录得股东应占净利润约900万元人民币,相比去年同期净亏损1,700万人民币。
过往派息
公布日期 | 派息事项 | 派息内容 |
---|---|---|
2025/03/31 | 末期业绩 | 无派息 |
2024/08/30 | 中期业绩 | 无派息 |
2024/03/28 | 末期业绩 | 无派息 |
2023/11/03 | 特别业绩 | 合并:10股合并为1股 |
集团表示,实现扭亏为盈,主要由于期内确认汇兑收益约1,600万元人民币所致。(hc/a)(港股报价延迟最少十五分钟。)AASTOCKS新闻
中科生物(01237.HK) 发盈喜,预期上半年将录得股东应占净利润约900万元人民币,相比去年同期净亏损1,700万人民币。
公布日期 | 派息事项 | 派息内容 |
---|---|---|
2025/03/31 | 末期业绩 | 无派息 |
2024/08/30 | 中期业绩 | 无派息 |
2024/03/28 | 末期业绩 | 无派息 |
2023/11/03 | 特别业绩 | 合并:10股合并为1股 |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.